Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Phio Pharmaceuticals Corp. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 17 | 16 | −1 |
| Shares | 700.4K | 899.0K | +198.6K (+28.4%) |
| Value | $1.58M | $1.82M | +$240.0K (+15.2%) |
New holders (3)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cetera Investment Advisers | 30,000 | $61.0K | 0.00% |
| Total Clarity Wealth Management, Inc. | 1,500 | $3.00K | 0.00% |
| Bank of America Corp | 63 | $0 | 0.00% |
Sold out (4)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Dimensional Fund Advisors LP | 23,960 | $54.0K |
| Goldman Sachs Group Inc | 19,002 | $43.0K |
| Two Sigma Securities, LLC | 17,099 | $39.0K |
| Tower Research Capital LLC (TRC) | 684 | $2.00K |